caa a22 4500 397591403 CHVBK 20180308164939.0 cr unu---uuuuu 161202e199605 xx s 000 0 eng 10.1093/jac/37.suppl_B.61 doi (NATIONALLICENCE)oxford-10.1093/jac/37.suppl_B.61 Recently recognised microbial enteropathies and HIV infection [Elektronische Daten] [Michael J. G. Farthing, M. Paul Kelly, Andrew M. Veitch] Persistent diarrhoea and small bowel enteropathy are important features of HIV infection. At least 80% of cases of persistent diarrhoea in patients with HIV/AIDS can be attributed to a specific enteropathogen. The coccidian parasites Cryptosporidium parvum, Isospora belli and Cyclospora and the Microsporidia account for at least 50% of cases of persistent diarrhoea in the industrialised and developing world with major contributions from Mycobacteriwn avium complex and other bacteria and cytomeglovirus. The intracellular protozoa can be detected on faecal microscopy although confirmation may be required by intestinal mucosal biopsies. Although up to 20% of cases of persistent diarrhoea can not be attributed to a specific infection, the question as to whether HIV infection itself can produce enteropathy remains uncertain. Recent developments in the treatment of persistent diarrhoea in HIV include the use of albendazole for microsporidial diarrhoea and co-trimoxazole for the treatment and eradication of Cyclospora. © 1996 The British Society for Antimicrobial Chemotherapy Articles nationallicence Farthing Michael J. G. Digestive Diseases Research Centre, Medical College of St Bartholomew's Hospital, Charterhouse Square, London EC1M 6BQ, UK aut Kelly M. Paul Digestive Diseases Research Centre, Medical College of St Bartholomew's Hospital, Charterhouse Square, London EC1M 6BQ, UK aut Veitch Andrew M. Digestive Diseases Research Centre, Medical College of St Bartholomew's Hospital, Charterhouse Square, London EC1M 6BQ, UK aut Journal of Antimicrobial Chemotherapy Oxford University Press 37(1996-05), 61-70 0305-7453 37<61 1996 37 jac https://doi.org/10.1093/jac/37.suppl_B.61 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1093/jac/37.suppl_B.61 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Farthing Michael J. G. Digestive Diseases Research Centre, Medical College of St Bartholomew's Hospital, Charterhouse Square, London EC1M 6BQ, UK aut NATIONALLICENCE 700 1- Kelly M. Paul Digestive Diseases Research Centre, Medical College of St Bartholomew's Hospital, Charterhouse Square, London EC1M 6BQ, UK aut NATIONALLICENCE 700 1- Veitch Andrew M. Digestive Diseases Research Centre, Medical College of St Bartholomew's Hospital, Charterhouse Square, London EC1M 6BQ, UK aut NATIONALLICENCE 773 0- Journal of Antimicrobial Chemotherapy Oxford University Press 37(1996-05), 61-70 0305-7453 37<61 1996 37 jac Metadata rights reserved CC BY-NC-4.0 http://creativecommons.org/licenses/by-nc/4.0 nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-oxford